IEZZI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 244
AS - Asia 121
EU - Europa 120
SA - Sud America 16
AF - Africa 2
Totale 503
Nazione #
US - Stati Uniti d'America 238
SG - Singapore 63
RU - Federazione Russa 35
IE - Irlanda 30
DE - Germania 20
CN - Cina 18
VN - Vietnam 15
BR - Brasile 14
HK - Hong Kong 12
UA - Ucraina 8
BD - Bangladesh 7
FI - Finlandia 6
IT - Italia 5
SE - Svezia 5
CA - Canada 3
GB - Regno Unito 3
JP - Giappone 3
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
HN - Honduras 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
EG - Egitto 1
ES - Italia 1
FR - Francia 1
IN - India 1
IQ - Iraq 1
MA - Marocco 1
MX - Messico 1
PL - Polonia 1
Totale 503
Città #
Singapore 33
Chandler 32
Dublin 30
San Jose 29
Dallas 24
Jacksonville 24
Ashburn 14
Hong Kong 12
The Dalles 11
Munich 10
New York 10
Santa Clara 10
Ann Arbor 7
Beijing 7
Ho Chi Minh City 7
Moscow 6
Boardman 4
Bremen 4
Columbus 4
Council Bluffs 4
Dearborn 4
Lawrence 4
Los Angeles 4
Orem 4
Princeton 4
Tokyo 3
Turku 3
Wilmington 3
Brno 2
Brooklyn 2
Brussels 2
Denver 2
Dong Ket 2
Helsinki 2
Seattle 2
Anyang 1
Argenteuil 1
Baghdad 1
Baltimore 1
Barranquilla 1
Cacoal 1
Cairo 1
Campo Grande 1
Cao Lanh 1
Cardiff 1
Casablanca 1
Charleston 1
Conceição do Coité 1
Concepción 1
Detroit 1
Dhaka 1
Falkenstein 1
Francavilla al Mare 1
Frankfurt am Main 1
Guangzhou 1
Haiphong 1
Hangzhou 1
Hanoi 1
Houston 1
Hải Dương 1
Ibiúna 1
João Câmara 1
Lanzhou 1
Lappeenranta 1
Lavras 1
Luís Antônio 1
Manchester 1
Maniwaki 1
Marietta 1
Medellín 1
Mexico City 1
Milan 1
Minneapolis 1
Poplar 1
Prudentópolis 1
Quận Ninh Kiều 1
Rio de Janeiro 1
Rohtak 1
San Pedro Sula 1
Stafford 1
Stockholm 1
São José do Rio Preto 1
São Paulo 1
Taiyuan 1
Tegucigalpa 1
Toronto 1
Tutóia 1
Urbandale 1
Verona 1
Viareggio 1
Vienna 1
Volta Redonda 1
Warsaw 1
Totale 383
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 151
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 124
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 122
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 110
Totale 507
Categoria #
all - tutte 2.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 1 0 0 5 0 0 4 1 0 1 5
2022/202384 4 8 1 12 8 8 0 4 39 0 0 0
2023/202426 4 1 1 0 1 10 0 0 0 1 1 7
2024/2025110 1 1 6 5 18 6 13 5 30 3 16 6
2025/2026211 14 13 22 20 21 19 29 12 18 25 8 10
2026/20274 4 0 0 0 0 0 0 0 0 0 0 0
Totale 507